Brief: Fulcrum Therapeutics Q1 Basic EPS USD -0.43
13/05/2024 12:00
May 13 (Reuters) - Fulcrum Therapeutics Q1 net income USD -26.87 million. * Q1 operating income USD -29.834 million vs. IBES estimate USD -29.6 million * Q1 operating expenses USD 29.834 million
Recent news on Fulcrum Therapeutics
See all newsFulcrum Therapeutics, Inc. expected to post a loss of 14 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE - Nvidia, Gold miners, Nike
U.S. STOCKS ON THE MOVE - Sunrun, JetBlue Airways, Dell Technologies
U.S. STOCKS ON THE MOVE - KBR, Vista Energy, Fulcrum Therapeutics
Fulcrum to merge with Slate in all-stock deal after drug setback